XML 18 R7.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2020
Mar. 31, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Dec. 31, 2019
CASH FLOWS FROM OPERATING ACTIVITIES:            
Net loss $ (7,321)   $ (8,977) $ (67,789) $ (19,560)  
Adjustments to reconcile net loss to net cash used in operating activities:            
Goodwill impairment   $ 27,450   27,450    
Depreciation and amortization       3,695 1,064  
Stock-based compensation       1,603 1,732  
Provision for bad debt 3,034 1,547   8,450 2,906 $ 9,991
Provision for inventory obsolescence       703 496  
Finance expenses       5,286 629  
Deferred tax expense (benefit)       (1,245) 467  
Interest on convertible promissory notes         370  
Change in fair value of earn-out liability       291 678  
Loss on sale of subsidiary       385    
Gain on disposal of property and equipment       35    
Changes in operating assets and liabilities:            
Accounts receivable short- and long-term       5,298 (19,102)  
Inventories       (1,612) 3,988  
Prepaid expenses       493 371  
Other current assets       (3,533) (2,865)  
Other long-term assets       6 (157)  
Trade payables       447 (860)  
Accrued expenses and other current liabilities       (6,584) 4,193  
Severance pay funds       142 (58)  
Unearned interest income       (1,630) 158  
Other long-term liabilities       (671) (317)  
Net cash used in operating activities       (28,780) (25,867)  
CASH FLOWS FROM INVESTING ACTIVITIES:            
Issuance of subordinated promissory notes         (4,500)  
Purchases of property and equipment       (208) (617)  
Cash paid for purchase of non-controlling interest         (123)  
Cash received from sale of subsidiary, net of cash relinquished       89    
Net cash used in investing activities       (119) (5,240)  
CASH FLOWS FROM FINANCING ACTIVITIES:            
Issuance of long-term debt, net of financing fees         9,740  
(Repayment of) proceeds from line-of-credit       (3,912) 1,917  
Proceeds from government assistance loans       4,110    
Proceeds from issuance of common stock       6,206    
Proceeds from 2020 Private Placement, net of costs of $1,950       20,300    
Dividends from subsidiaries paid to non-controlling interest       (218)    
Proceeds from issuance of convertible promissory notes, net of cash issuance costs of $280         28,770  
Payment of earn-out liability       (549) (451)  
Installment payments         (250)  
Proceeds from exercise of options       74 355  
Net cash provided by financing activities       26,011 40,081  
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH       (2,888) 8,974  
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH — Beginning of period   $ 15,749   15,749 6,758 6,758
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH — End of period $ 12,861   $ 15,732 12,861 15,732 $ 15,749
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:            
Cash paid for income taxes       461 529  
Cash paid for interest       988 4,620  
SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING INFORMATION:            
Purchase of non-controlling interest         $ 68  
Beneficial conversion feature of preferred stock recorded as deemed dividend       3,564    
Common stock issuance costs       620    
Conversion of Series A convertible preferred stock       $ 660